Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


BioMarin Resubmits Marketing Authorization Application To European Medicines Agency For Valoctocogene Roxaparvovec To Treat Severe Hemophilia A


Benzinga | Jun 28, 2021 08:45AM EDT

BioMarin Resubmits Marketing Authorization Application To European Medicines Agency For Valoctocogene Roxaparvovec To Treat Severe Hemophilia A






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC